Seeking Alpha

STML
  Stemline Therapeutics - NASDAQ

10/20/2014, 9:29 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
STML vs. ETF Alternatives
Company Description
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.